Ochratoxin A at nanomolar concentrations: A signal modulator in renal cells

Molecular Nutrition and Food Research

Volumn 49, Issue 2, 2005, Pages 118-130

  Gekle, Michael ^a   Sauvant, Christoph ^a   Schwerdt, Gerald ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cellular signalling networks; Ochratoxin A; Renal cells; Review

Indexed keywords

CALCIUM ION; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OCHRATOXIN; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; CELL DIFFERENTIATION; CELL INTERACTION; CHEMICAL INTERACTION; CONCENTRATION (PARAMETERS); CONTAMINATION; ELECTROLYTE BALANCE; ENERGY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FOOD CONTAMINATION; GLOMERULUS; HEALTH HAZARD; HOMEOSTASIS; HUMAN; HYDROLYSIS; KIDNEY CELL; KIDNEY COLLECTING TUBULE; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; METABOLISM; NEPHROTOXICITY; NONHUMAN; PATHOGENESIS; PH MEASUREMENT; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TOXICITY;

ANIMALS; CALCIUM; CELL DIFFERENTIATION; ENERGY METABOLISM; ENVIRONMENTAL EXPOSURE; HUMANS; HYDROGEN-ION CONCENTRATION; KIDNEY; KIDNEY DISEASES; MITOGEN-ACTIVATED PROTEIN KINASES; OCHRATOXINS; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 15044361939     PISSN: 16134125     EISSN: None     Source Type: Journal    
DOI: 10.1002/mnfr.200400062     Document Type: Review

References (108)

1. Creppy, E. E., Kane, A., Giessen-Crouse, E., Roth, A., et al., Effect of ochratoxin A on enzyme activities and macromolecules synthesis in MDCK cells. Arch. Toxicol. Suppl. 1986, 9, 310-314.
2. Luhe, A., Hildebrand, H., Bach, U., Dingermann, T., Ahr, H. J., A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: expression profiling in vivo and in vitro employing cDNA microarrays. Toxicol. Sci. 2003, 73, 315-328.
3. Schaaf, G. J., Nijmeijer, S. M., Maas, R. F., Roestenberg, P., et al., The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells. Biochim. Biophys. Acta 2002, 1588, 149-158.
4. van der Merwe, K. J., Steyn, P. S., Fourie, L., Scott, D. B., Theron, J. J., Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus Wilh. Nature 1965, 205, 1112-1113.
5. van der Merwe, K. J., Steyn, P. S., Fourie, L., Mycotoxins. II. The constitution of ochratoxins A, B, and C, metabolites of Aspergillus ochraceus Wilh. J. Chem. Soc. Perkin 1965, 1, 7083-7088.
6. Ciegler, A., Fennell, D. J., Mintzlaff, H. J., Leistner, L., Ochratoxin synthesis by Penicillium species. Naturwissenschaften 1972, 59, 365-366.
7. Carlton, W. W., Tuite, J., Caldwell, R., Penicillium viridicatum toxins and mold nephrosis. J. Am. Vet. Med. Assoc. 1973, 163, 1295-1297.
8. Purchase, I. F., Theron, J. J., The acute toxicity of ochratoxin A to rats. Food Cosmet. Toxicol. 1968, 6, 479-483.
9. Szczech, G. M., Carlton, W. W., Tuite, J., Caldwell, R., Ochratoxin A toxicosis in swine. Vet. Pathol. 1973, 10, 347-364.
10. Suzuki, S., Sato, T., Effects of ochratoxin A on tissue glycogen levels in rats. Jpn. J. Pharmacol. 1973, 23, 415-419.
11. Szczech, G. M., Carlton, W. W., Hinsman, E. J., Ochratoxicosis in Beagle dogs. III. Terminal renal ultrastructural alterations. Vet. Pathol. 1974, 11, 385-406.
12. Theron, J. J., Merwe, K. J., Liebenberg, N., Joubert, H. J., Nel, W., Acute liver injury in ducklings and rats as a result of ochratoxin poisoning. J. Pathol. Bacteriol. 1966, 91, 521-529.
13. Krogh, P., Axelsen, N. H., Elling, F., Gryd-Hansen, N., et al., Experimental porcine nephropathy. Acta Pathol. Microbiol. Scand. A 1974, 246, 1-21.
14. Berndt, W. O., Hayes, A. W., In vivo and in vitro changes in renal function caused by ochratoxin A in the rat. Toxicology 1979, 12, 5-17.
15. Creppy, E. E., Röschenthaler, R., Dirheimer, G., Inhibition of protein synthesis in the mice by ochratoxin-A and its prevention by phenylalanine. Food Chem. Toxicol. 1984, 22, 883-886.
16. Krogh, P., Hald, B., Plestina, R., Ceovic, S., Balkan (endemic) nephropathy and foodborn ochratoxin A: preliminary results of a survey of foodstuffs. Acta Pathol. Microbiol. Scand. B 1977, 85, 238-240.
17. Delacruz, L., Bach, P. H., The role of ochratoxin A metabolism and biochemistry in animal and human nephrotoxicity. J. Biopharm. Sci. 1990, 1, 277-304.
18. Kuiper-Goodman, T., Scott, P. M., Risk assessment of the mycotoxin ochratoxin A. Biomed. Environ. Sci. 1989, 2, 179-248.
19. Galtier, P., Camguilhem, R., Evidence for in vitro and in vivo interaction between ochratoxin A and three acidic drugs. Toxicology 1979, 18, 493-496.
20. Stojkovic, R., Hult, K., Gamulin, S., Plestina, R., High affinity binding of ochratoxin A to plasma constituents. Biochem. Int. 1984, 9, 33-38.
21. Kiessling, K. H., Pettersson, H., Sandholm, K., Olsen, M., Metabolism of aflatoxin, ochratoxin, zearalenone, and three trichothecenes by intact rumen fluid, rumen protozoa, and rumen bacteria. Appl. Environ. Microbiol. 1984, 47, 1070-1073.
22. Stormer, F. C., Storen, O., Hansen, C. E., Pedersen, J. I., Aasen, A. J., Formation of (4R)- and (4S)-4-hydroxyochratoxin A and 10-hydroxyochratoxin A from ochratoxin A by rabbit liver microsomes. Appl. Environ. Microbiol. 1983, 45, 1183-1187.
23. Syvertsen, C., Stormer, F. C., Oxidation of two hydroxylated ochratoxin A metabolites by alcohol dehydrogenase. Appl. Environ. Microbiol. 1983, 45, 1701-1703.
24. Miraglia, M., Brera, C., Pazzaglini, B., Grossi, S., Assessment of dietary intake of ochratoxin A by the population of EU member states. Directorate General Health and Consumer Protection. Task 3.2.7, 1-153. 2002. Brussels, European Union. Reports on tasks for scientific cooperation.
25. Petkova-Bocharova, T., Castegnaro, M., Ochratoxin A contamination of cereals in an area of high incidence of Balkan endemic nephropathy in Bulgaria. Food Addit. Contam. 1985, 2, 267-270.
26. Godin, M., Francois, A., Le Roy, E., Doublet, B., et al., Karyomegalic interstitial nephritis: Is ochratoxin A responsible? (abstract) J. Am. Soc. Nephrol. 1995, 6, 997.
27. Maaroufi, K., Achour, A., Betbeder, A. M., Hammami, M., et al., Foodstuffs and human blood contamination by the mycotoxin ochratoxin A: correlation with chronic interstitial nephropathy in Tunisia. Arch. Toxicol. 1995, 69, 552-558.
28. Maaroufi, K., Achour, A., Hammami, M., el May, M., et al., Ochratoxin A in human blood in relation to nephropathy in Tunisia. Hum. Exp. Toxicol. 1995, 14, 609-614.
29. Radic, B., Fuchs, R., Peraica, M., Lucic, A., Ochratoxin A in human sera in the area with endemic nephropathy in Croatia. Toxicol. Lett. 1997, 91, 105-109.
30. Simon, P., Ochratoxin and kidney disease in the human. J. Toxicol. 1996, 15, 239-249.
31. Wafa, E. W., Yahya, R. S., Sobh, M. A., Eraky, I., et al., Human ochratoxicosis and nephropathy in Egypt: a preliminary study. Hum. Exp. Toxicol. 1998, 17, 124-129.
32. Petronic, V. J., Bukurov, N. S., Djokic, M. R., Milenkovic, D. Z., et al., Balkan endemic nephropathy and papillary transitional cell tumors of the renal pelvis and ureters. Kidney Int. 1991, 40, 77-79.
33. Radovanovic, Z., Jankovic, S., Jevremovic, I., Incidence of tumors of urinary organs in a focus of Balkan endemic nephropathy. Kidney Int. 1991, 40, 75-76.
34. Bach, P. H., Morin, J.-P., Pfaller, W., Nephrotoxicity - What we have learned and what we still need to know! TEN 1996, 3, 4-13.
35. Marquardt, R. R., Fröhlich, A. A., A review of recent advances in understanding ochratoxicosis. J. Anim. Sci. 1992, 70, 3968-3988.
36. Gekle, M., Silbernagl, S., The role of the proximal tubule in ochratoxin A nephrotoxicity in vivo: toxodynamic and toxokinetic aspects. Renal Physiol. Biochem. 1994, 17, 40-49.
37. Zimmerli, B., Dick, R., Determination of ochratoxin A at ppt level in human blood, serum, milk and some foodstuffs by high-performance liquid chromatography with enhanced fluorescence detection and immunoaffinity column cleanup: methodology and Swiss data. J. Chromatogr. A 1995, 666, 85-99.
38. Alvarez, L., Gil, A. G., Ezpeleta, O., Garcia-Jalon, J. A., Lopez, D. C., Immunotoxic effects of ochratoxin A in Wistar rats after oral administration. Food Chem. Toxicol. 2004, 42, 825-834.
39. Aydin, G., Ozcelik, N., Cicek, E., Soyoz, M., Histopathologic changes in liver and renal tissues induced by ochratoxin A and melatonin in rats. Hum. Exp. Toxicol. 2003, 22, 383-391.
40. Monnet-Tschudi, F., Sorg, O., Honegger, P., Zurich, M.-G., et al., Effects of the naturally occurring food mycotoxin ochratoxin A on brain cells in culture. NeuroToxicology 1997, 18, 831-840.
41. Bahnemann, E., Kerling, H. P., Ensminger, S., Schwerdt, G., et al., Renal transepithelial secretion of ochratoxin A in the non-filtering toad kidney. Toxicology 1997, 120, 11-17.
42. Dahlmann, A., Dantzler, W. H., Silbernagl, S., Gekle, M., Detailed mapping of ochratoxin A reabsorption along the rat nephron in vivo: The nephrotoxin can be reabsorbed in all nephron segments by different mechanisms. J. Pharmacol. Exp. Ther. 1998, 286, 157-162.
43. Gekle, M., Silbernagl, S., Mildenberger, S., Freudinger, R., Effect on dome formation and uptake of ochratoxin A in proximal tubule-derived opossum kidney cell monolayers. Cell Physiol. Biochem. 1993, 3, 68-77.
44. Sauvant, C., Silbernagl, S., Gekle, M., Exposure to ochratoxin A impairs organic anion transport in proximal tubule-derived OK-cells. J. Pharmacol. Exp. Ther. 1998, 287, 13-20.
45. Schwerdt, G., Gekle, M., Freudinger, R., Mildenberger, S., Silbernagl, S., Apical-to-basolateral transepithelial transport of ochratoxin A by two subtypes of Madin-Darby canine kidney cells. Biochim. Biophys. Acta 1997, 1324, 191-199.
46. Zingerle, M., Silbernagl, S., Gekle, M., Reabsorption of the nephrotoxin ochratoxin A along the rat nephron in vivo. J. Pharmacol. Exp. Ther. 1997, 280, 220-224.
47. Schwerdt, G., Bauer, K., Gekle, M., Silbernagl, S., Accumulation of ochratoxin A in rat kidney in vivo and in cultivated renal epithelial cells in vitro. Toxicology 1996, 114, 177-185.
48. Gekle, M., Silbernagl, S., Mechanism of ochratoxin A-induced reduction of glomerular filtration rate. J. Pharmacol. Exp. Ther. 1993, 276, 316-321.
49. Gekle, M., Silbernagl, S., Renal toxicodynamics of ochratoxin A: A pathophysiological approach. Kidney Blood Press Res. 1996, 19, 225-235.
50. Meisner, H., Chan, S., Ochratoxin A, an inhibitor of mitochondrial transport systems. Biochemistry 1974, 13, 2795-2800
51. Meisner, H., Selanik, P., Inhibition of renal gluconeogenesis in rats by ochratoxin. Biochem. J. 1979, 180, 681-684.
52. Sauvant, C., Holzinger, H., Gekle, M., Exposure to nephrotoxic ochratoxin A leads to generation of collagen in human renal proximal tubular cells. Mol. Nutr. Food Res. 2005, in press
53. Gekle, M., Oberleithner, H., Silbernagl, S., Ochratoxin A impairs postproximal nephron function in vivo and blocks plasma membrane anion conductance in Madin-Darby canine kidney cells in vitro. Pflügers Arch. 1993, 425, 401-408.
54. Kastner, P. R., Hall, J. E., Guyton, A. C., Control of glomerular filtration rate: role of intrarenally formed angiotensin II. Am. J. Physiol. 1984, 246, F897-F906.
55. Van Aubel, R. A. M. H., Masereeuw, R., Russel, F. G. M., Molecular pharmacology of renal organic anion transporters. AJP - Renal Physiol. 2000, 279, F216-F232.
56. Sweet, D. H., Wolff, N. A., Pritchard, J. B., Expression cloning and characterization of ROAT1. J. Biol. Chem. 1998, 272, 30088-30095.
57. Hasegawa, M., Kusuhara, H., Sugiyama, D., Ito, K., et al., Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions. J. Pharmacol. Exp. Ther. 2002, 300, 746-753.
58. + gradient. AJP - Renal Physiol. 2003, 284, F763-F769.
59. Zhang, X., Groves, C. E., Bahn, A., Barendt, W. M., et al., Relative contribution of OAT and OCT transporters to organic electrolyte transport in rabbit proximal tubule. Am. J. Physiol. 2004, 287, F999-F1010.
60. Mego, J. L., Hayes, A. W. Effect of fungal toxins on uptake and degradation of formaldehyde-treated 1251-albumin in mouse liver phagolysosomes. Biochem. Pharmacol. 1973, 22, 3275-3286.
61. Gekle, M., Mildenberger, S., Freudinger, R., Silbernagl, S., The mycotoxin ochratoxin A impairs protein uptake in cells derived from the proximal tubule of the kidney (opossum kidney cells). J. Pharmacol. Exp. Ther. 1994, 271, 1-6.
62. Sauvant, C., Holzinger, H., Gekle, M., The nephrotoxin Ochratoxin A induces key parameters of chronic interstitial nephropathy in renal proximal tubular cells. Cell Physiol. Biochem. 2005, in press.
63. NTP: Technical report on the toxicology and carcinogenesis studies of ochratoxin A (CAS NO. 303-47-9) in F344/N rats (Gavage studies). Research Triangle Park, NC., NHI Publication No. 89-2813. U.S. Department of Health and Human Services, 1989.
64. Hamm, L. L., Alpern, R. J., Cellular mechanism of renal tubular acidification, in: Seldin, D. W., Giebisch, G. (Eds.), The Kidney: Physiology and pathophysiology, 2ed., Raven Press, New York 1992, pp. 2581-2626.
65. Kuramochi, G., Gekle, M., Silbernagl, S., Derangement of pH homeostasis in renal papilla: Ochratoxin A increases pH in vasa recta blood. Nephron 1997, 76, 472-476.
66. - in the tubule and vasa recta. Pflügers Arch. 1997, 434, 392-397.
67. Gekle, M., Pollock, C. A., Silbernagl, S., Time- and concentration- dependent biphasic effect of ochratoxin A on growth of proximal tubular cells in primary culture. J. Pharmacol. Exp. Ther. 1995, 275, 397-404.
68. Petrik, J., Zanic-Grubisic, T., Barisic, K., Pepeljnjak, S., et al., Apoptosis and oxidative stress induced by ochratoxin A in rat kidney. Arch. Toxicol. 2003, 77, 685-693.
69. Schwerdt, G., Freudinger, R., Mildenberger, S., Silbernagl, S., Gekle, M., The nephrotoxin ochratoxin A induces apoptosis in cultured human proximal tubule cells. Cell. Biol. Toxicol. 1999, 15, 405-415.
70. Eder, S., Benesic, A., Freudinger, R., Engert, J., et al., Nephritogenic ochratoxin A interferes with mitochondrial function and pH homeostasis in immortalized human kidney epithelial cells. Pflügers Arch. 2000, 40, 521-529.
71. Gekle, M., Vogt, R., Oberleithner, H., Silbernagl, S., The mycotoxin ochratoxin A deranges pH homeostasis in Madin-Darby canine kidney cells. J. Membrane Biol. 1994, 139, 183-190.
72. Valverde, M. A., Hardy, S. P., Sepulveda, F. V., Chloride channels: a state of flux. FASEB J. 1995, 9, 509-515.
73. Schramek, H., Wilflingseder, D., Pollack, V., Freudinger, R., et al., Ochratoxin A-induced stimulation of extracellular signal-regulated kinases 1/2 is associated with Madin-Darby canine kidney-C7 cell dedifferentiation. J. Pharmacol. Exp. Ther. 1997, 283, 1460-1468.
74. Gekle, M., Schwerdt, G., Freudinger, R., Mildenberger, S., et al., Ochratoxin A induces JNK activation and apoptosis in MDCK-C7 cells at nanomolar concentrations. J. Pharmacol. Exp. Ther. 2000, 293, 837-844.
75. Schwerdt, G., Freudinger, R., Schuster, C., Silbernagl, S., Gekle, M., Inhibition of mitochondria and extracellular acidification enhance ochratoxin A-induced apoptosis in renal collecting duct-derived MDCK-C7 cells. Cell Physiol. Biochem. 2004, 14, 47-56.
76. Aleo, M. D., Wyatt, R. D., Schnellmann, R. G., Mitochondrial dysfunction is an early event in ochratoxin A but not in oosporein toxicity to rat renal proximal tubules. Toxicol. Appl. Pharmacol. 1991, 107, 73-80.
77. Obrecht-Pflumio, S., Dirheimer, G., In vitro DNA and dGMP adducts formation caused by ochratoxin A. Chem. Biol. Interact. 2000, 127, 29-44.
78. Rahimtula, A. D., Bèrèziat, J.-C., Bussacchini-Griot, V., Bartsch, H., Lipid peroxidation as a possible cause of ochratoxin A toxicity. Biochem. Pharmacol. 1987, 37, 4469-4477.
79. Benesic, A., Mildenberger, S., Gekle, M., Nephritogenic ochratoxin A interferes with hormonal signaling of immortalized human kidney epithelial cells. Pflügers Arch. 2000, 439, 278-287.
80. Schwerdt, G., Freudinger, R., Schuster, C., Silbernagl, S., Gekle, M., Inhibition of mitochondria prevents cell death in kidney epithelial cells by intra- and extracellular acidification. Kidney Int. 2003, 63, 1725-1735.
81. Bokemeyer, D., Sorokin, A., Dunn, M. J., Multiple intracellular MAP kinase signaling cascades. Kidney Int. 1996, 49, 1187-1198.
82. Robinson, M. J., Cobb, M. H., Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 1997, 9, 180-186.
83. Seger, R., Krebs, E. G., The MAPK signaling cascade. FASEB J. 1995, 9, 726-735.
84. Tian, W., Zhang, Z., Cohen, D. M., MAPK signaling and the kidney. AJP - Renal Physiol. 2000, 279, F593-F604.
85. Gekle, M., Gaßner, B., Freudinger, R., Mildenberger, S., et al., Characterization of an ochratoxin-A-dedifferentiated and cloned renal epithelial cell line. Toxicol. Appl. Pharmacol. 1998, 152, 282-291.
86. Gupta, S., Barrett, T., Whitmarsh, A. J., Cavanagh, J., et al., Selective interaction of JNK protein kinase isoforms with transcription factors. Embo J. 1996, 15, 2760-2770.
87. Whitmarsh, A. J., Davis, R. J., Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 1996, 74, 589-607.
88. Teng, D. H., Perry III, W. L., Hogan, J. K., Baumgard, M., et al., Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res. 1997, 57, 4177-4182.
89. Nishina, H., Fischer, K. D., Radvanyl, L., Shahinian, A., et al., Stress-signaling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 1997, 385, 350-353.
90. Pearson, G., Robinson, F., Beers Gibson, T., Xu, B., et al., Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions. Endocr. Rev. 2001, 22, 153-183.
91. 2 cytotoxicity in mouse renal proximal tubule cells. Kidney Int. 2004, 65, 1231-1239.
92. Pfohl-Leszkowicz, A., Petkova-Bocharova, T., Chernozemsky, I. N., Castegnaro, M., Balkan endemic nephropathy and associated urinary tract tumours: a review on aetiological causes and the potential role of mycotoxins. Food Addit. Contam. 2002, 19, 282-302.
93. Oka, H., Chatani, Y., Hoshino, R., Ogawa, O., et al., Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res. 1995, 55, 4182-4187.
94. Cuadrado, A., Garcia-Fernandez, L. F., Gonzalez, L., Suarez, Y., et al., Aplidin TM induces apoptosis in human cancer cells via glutathione depletion and sustained activation of the epidermal growth factor receptor, Src, JNK, and p38 MAPK. J. Biol. Chem. 2003, 278, 241-250.
95. Yang, J., Liu, Y., Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am. J. Pathol. 2001, 159, 1465-1475.
96. Kerr, J. F., Wyllie, A. H., Currie, A. R., Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972, 26, 239-257.
97. Sugiyama, H., Kashihara, N., Makino, H., Yamasaki, Y., Ota, A., Apoptosis in glomerular sclerosis. Kidney Int. 1996, 49, 103-111.
98. Thomas, S. E., Andoh, T. F., Pichler, R. H., Shankland, S. J., et al., Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int. 1998, 53, 897-908.
99. Wilson, P. D., Polycystic kidney disease. N. Engl. J. Med. 2004, 350, 151-164.
100. Woo, D., Apoptosis and loss of renal tissue in polycystic kidney diseases. N. Engl. J. Med. 1995, 333, 18-25.
101. Ortiz, A., Lorz, C., Justo, P., Catalan, M. P., Egido, J., Contribution of apoptotic cell death to renal injury. J. Cell Mol. Med. 2001, 5, 18-32.
102. Mantle, P. G., Milijkovic, A., Udupa, V., Dobrota, M., Does apoptosis cause renal atrophy in Balkan endemic nephropathy? Lancet 1998, 352, 1118-1119.
103. Robbiano, L., Baroni, D., Carrozzino, R., Mereto, E., Brambilla, G., DNA damage and micronuclei induced in rat and human kidney cells by six chemicals carcinogenic to the rat kidney. Toxicology 2004, 204, 187-195.
104. Antonsson, B., Bax and other pro-apoptotic Bcl-2 family "killer-proteins" and their victim the mitochondrion. Cell Tissue Res. 2001, 306, 347-361.
105. Reed, J. C., Jurgensmeier, J. M., Matsuyama, S., Bcl-2 family proteins and mitochondria. Biochim. Biophys. Acta 1998, 1366, 127-137.
106. Marchetti, P., Castedo, M., Susin, S. A., Zamzami, N., et al., Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 1996, 184, 1155-1160.
107. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., Wang, X., Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91, 479-489.
108. Weber, F., Freudinger, R., Schwerdt, G., Gekle, M., A rapid screening method to test apoptotic synergisms of ochratoxin A with other nephrotoxic substances. Toxicol. In Vitro 2005, 79, 135-143.